RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
6.57
+0.31 (4.95%)
At close: Aug 10, 2026, 4:00 PM EDT
6.58
+0.01 (0.15%)
After-hours: Aug 10, 2026, 7:34 PM EDT
RxSight Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 13.35 | 19.95 | 16.71 | 9.69 | 11.83 | 24.36 |
Short-Term Investments | 195.45 | 208.18 | 220.52 | 117.49 | 93.97 | 134.97 |
Cash & Short-Term Investments | 208.8 | 228.13 | 237.22 | 127.18 | 105.8 | 159.33 |
Cash Growth | -8.22% | -3.83% | 86.52% | 20.21% | -33.60% | 131.00% |
Accounts Receivable | 18.52 | 23.38 | 30.05 | 20.28 | 10.96 | 4.86 |
Other Receivables | 60 | - | - | - | - | - |
Total Trade Receivables | 78.52 | 23.38 | 30.05 | 20.28 | 10.96 | 4.86 |
Inventory | 37.12 | 31.56 | 22.01 | 17.42 | 14.84 | 8.03 |
Other Current Assets | 2.96 | 4.39 | 4.54 | 3.52 | 2.96 | 4.07 |
Total Current Assets | 327.4 | 287.46 | 293.82 | 168.41 | 134.56 | 176.3 |
Net Property, Plant & Equipment | 23.53 | 23.02 | 23.63 | 13.29 | 14.08 | 15.5 |
Other Long-Term Assets | 1.77 | 1.34 | 1.11 | 0.86 | 1.53 | 0.93 |
Total Assets | 352.7 | 311.81 | 318.56 | 182.55 | 150.16 | 192.72 |
Accounts Payable | 6.35 | 5.3 | 4.54 | 3.86 | 2.6 | 1.69 |
Accrued Expenses | 15.55 | 19.8 | 20.36 | 15.24 | 12.67 | 7.86 |
Current Portion of Leases | 1.66 | 1.16 | 0.97 | 1.8 | 1.97 | 1.53 |
Unearned Revenue | 6.88 | - | - | - | - | - |
Other Current Liabilities | 50 | - | - | - | - | - |
Total Current Liabilities | 80.44 | 26.25 | 25.88 | 20.9 | 17.24 | 11.08 |
Long-Term Debt | - | - | - | - | 40.17 | 39.76 |
Long-Term Leases | 8.92 | 9.88 | 11.32 | 1.21 | 2.86 | 3.64 |
Other Long-Term Liabilities | - | - | 0.13 | 0.07 | - | - |
Total Long-Term Liabilities | 8.92 | 9.88 | 11.45 | 1.29 | 43.03 | 43.4 |
Total Liabilities | 89.36 | 36.13 | 37.33 | 22.19 | 60.26 | 54.48 |
Common Stock | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0 |
Additional Paid-in Capital | 952.38 | 936.63 | 903.13 | 754.97 | 636 | 617.51 |
Accumulated Other Comprehensive Income | -0.06 | 0.05 | 0.17 | -0.01 | -0.1 | -0.02 |
Retained Earnings | -689.02 | -661.04 | -622.1 | -594.64 | -546.03 | -479.28 |
Total Common Shareholders' Equity | 263.34 | 275.68 | 281.24 | 160.36 | 89.9 | 138.22 |
Shareholders' Equity | 263.34 | 275.68 | 281.24 | 160.36 | 89.9 | 138.22 |
Total Liabilities & Equity | 352.7 | 311.81 | 318.56 | 182.55 | 150.16 | 192.72 |
Total Debt | 10.58 | 11.04 | 12.3 | 3.01 | 45 | 44.93 |
Net Cash (Debt) | 198.22 | 217.09 | 224.93 | 124.17 | 60.81 | 114.4 |
Net Cash Growth | -8.14% | -3.48% | 81.14% | 104.20% | -46.85% | 199.30% |
Net Cash Per Share | 4.81 | 5.31 | 5.79 | 3.60 | 2.20 | 8.40 |
Book Value | 263.34 | 275.68 | 281.24 | 160.36 | 89.9 | 138.22 |
Book Value Per Share | 6.39 | 6.75 | 7.24 | 4.65 | 3.25 | 10.14 |
Tangible Book Value | 263.34 | 275.68 | 281.24 | 160.36 | 89.9 | 138.22 |
Tangible Book Value Per Share | 6.39 | 6.75 | 7.24 | 4.65 | 3.25 | 10.14 |